1.Addressing challenges in the clinical applications associated with CRISPR/Cas9 technology and ethical questions to prevent its misuse.
Xiang Jin KANG ; Chiong Isabella Noelle CAPARAS ; Boon Seng SOH ; Yong FAN
Protein & Cell 2017;8(11):791-795
		                        		
		                        		
		                        		
		                        			Animals
		                        			;
		                        		
		                        			CRISPR-Cas Systems
		                        			;
		                        		
		                        			Cystic Fibrosis
		                        			;
		                        		
		                        			genetics
		                        			;
		                        		
		                        			therapy
		                        			;
		                        		
		                        			Gene Editing
		                        			;
		                        		
		                        			ethics
		                        			;
		                        		
		                        			Genetic Therapy
		                        			;
		                        		
		                        			ethics
		                        			;
		                        		
		                        			methods
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Mice
		                        			;
		                        		
		                        			Neoplasms
		                        			;
		                        		
		                        			genetics
		                        			;
		                        		
		                        			therapy
		                        			
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail